PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Lenalidomide
Presentation Product Chemical substance Chapter Items dispensed
Lenalidomide 25mg capsules
0802040Y0AAADAD
Lenalidomide Lenalidomide Malignant Disease and Immunosuppression 1
Revlimid 10mg capsules
0802040Y0BBABAB
Revlimid Lenalidomide Malignant Disease and Immunosuppression 1
Lenalidomide 10mg capsules
0802040Y0AAABAB
Lenalidomide Lenalidomide Malignant Disease and Immunosuppression No data available
Lenalidomide 15mg capsules
0802040Y0AAACAC
Lenalidomide Lenalidomide Malignant Disease and Immunosuppression No data available
Lenalidomide 2.5mg capsules
0802040Y0AAAEAE
Lenalidomide Lenalidomide Malignant Disease and Immunosuppression No data available
Lenalidomide 20mg capsules
0802040Y0AAAGAG
Lenalidomide Lenalidomide Malignant Disease and Immunosuppression No data available
Lenalidomide 5mg capsules
0802040Y0AAAAAA
Lenalidomide Lenalidomide Malignant Disease and Immunosuppression No data available
Lenalidomide 7.5mg capsules
0802040Y0AAAFAF
Lenalidomide Lenalidomide Malignant Disease and Immunosuppression No data available
Revlimid 15mg capsules
0802040Y0BBACAC
Revlimid Lenalidomide Malignant Disease and Immunosuppression No data available
Revlimid 2.5mg capsules
0802040Y0BBAEAE
Revlimid Lenalidomide Malignant Disease and Immunosuppression No data available
Revlimid 20mg capsules
0802040Y0BBAGAG
Revlimid Lenalidomide Malignant Disease and Immunosuppression No data available
Revlimid 25mg capsules
0802040Y0BBADAD
Revlimid Lenalidomide Malignant Disease and Immunosuppression No data available
Revlimid 5mg capsules
0802040Y0BBAAAA
Revlimid Lenalidomide Malignant Disease and Immunosuppression No data available
Revlimid 7.5mg capsules
0802040Y0BBAFAF
Revlimid Lenalidomide Malignant Disease and Immunosuppression No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.